Literature DB >> 3486441

Immune factors in narcolepsy.

N Langdon, C Lock, K Welsh, D Vergani, R Dorow, H Wachtel, D Palenschat, J D Parkes.   

Abstract

Most but not all subjects with the narcoleptic syndrome have the human leukocyte antigen (HLA) DR2 (and DQ1). The narcolepsy-DR2 association is the highest disease-HLA linkage known, and occurs in nonfamilial as well as familial cases of the narcoleptic syndrome. In other forms of daytime drowsiness, there is no relationship with a specific HLA, although some subjects considered to have "essential" hypersomnolence probably have the narcoleptic syndrome. The cause of the narcoleptic syndrome remains unknown, although in a few instances the condition follows infection. There is no evidence for a circulating sleep factor in the blood or in the cerebrospinal fluid of narcoleptic subjects, and no unequivocal marker of cellular immunity has yet been found. However, a few subjects with the narcoleptic syndrome have oligoclonal bands or raised immunoglobulin concentration in the cerebrospinal fluid. It is highly likely that the narcoleptic syndrome is an immune-mediated disorder, occurring in a genetically susceptible (DR2/DQ1-positive) subject.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486441

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  5 in total

1.  Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings.

Authors:  Secil Aydinoz; Yu-Shu Huang; David Gozal; Clara O Inocente; Patricia Franco; Leila Kheirandish-Gozal
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

2.  HLA-DR2 negative narcolepsy.

Authors:  C Confavreux; L Gebuhrer; H Betuel; C Freidel; H Bastuji; G Aimard; M Devic; M Jouvet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

Review 3.  Genetic factors in sleep disorders.

Authors:  J D Parkes; C B Lock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

4.  Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.

Authors:  M Onofrj; L Curatola; F Ferracci; T Fulgente
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

5.  MHC class II sequences of an HLA-DR2 narcoleptic.

Authors:  C B Lock; A K So; K I Welsh; J D Parkes; J Trowsdale
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.